Zyprexa

If this is your release, you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release.

Please do not contact PRWeb.

We will be unable to assist you with your inquiry.

PRWeb disclaims any content contained in these releases.

Our complete disclaimer appears here.

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.

Please do not contact PR Web™.

We will be unable to assist you with your inquiry.

PR Web™ disclaims any content contained in these releases.

Our complete disclaimer appears here.

© Copyright 1997-2005, PRWeb™.

All Rights Reserved Terms of Service | Privacy Policy ...

It's best to consult a medical expert before considering any medications as the patient's medical history needs to be taken into consideration as well as possible side effects.

Born in Oklahoma, in 1951, Karen L Simmons had her first book published in 1996.

The book, Little Rainman, Autism Through The Eyes of A Child was written to raise awareness about the early detection signs of autism and has sold over 10,000 copies worldwide to parents and educators of these special children.

Autism Today is your #1 shop for all your Autism and Autism Spectrum disorders.

Look us up at AutismToday.com.

This article represents the views and opinions of the author and not of www.dailyindia.com. Recent News Get Heartburn, Indigestion and Ulcer Relief Using DGLEating Bran to Eliminate ConstipationClub Drugs: The BasicsPeriodontal Disease, Gum Disease, Gum Infections - Linked to Chronic Lung DiseaseHow To Lose Weight Easily, Quickly And Naturally Program - Natural Weight LossThe Bacteria And Other Microorganisms That Are Involved In Dental Infection Copyright © 2005 DailyIndia.com Contact Us ...

An AstraZeneca spokesperson questioned the study's methodology, saying the profit estimate for Seroquel, a schizophrenia medication, was too high.

AstraZeneca gave no alternative figures.

A GlaxoSmithKline spokesperson wouldn't discuss projected earnings for Lamictal, a treatment for bipolar disorder.

A spokesperson for Lilly said the company expected only a "modest short-term benefit to sales" for sales of $2.04 billion in 2005.

Lilly's earnings per share could rise by 6 percent in 2006 just by escaping the rebates, the Prudential study estimates.

With U.S.

sales of $2.76 billion in 2005, Seroquel's increased Medicare profit could boost AstraZeneca's earnings per share by 8 percent, the report found.

Company policy prohibits Prudential analysts from discussing reports with nonclients, said company spokesman Jim Gorman.

Tony Butler, managing director and pharmaceutical analyst at Lehman Bros., an investment bank in New York, agreed with the report that Medicare would probably have higher drug prices than Medicaid.

Butler estimated the sales windfall for drug companies under Medicare to be $1.8 billion ...